Clinical Trial Update: SGA-induced Metabolic Syndrome in Bipolar Youth [Phase 3]

View source ↗

Summary

Phase 3 trial investigating SGA-induced metabolic syndrome in bipolar youth has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder in Children and Adolescents

Snippet

Sponsor: University of Cincinnati | Conditions: Bipolar Youth Treated With Second-generation Antipsychotics | Phase 3 | Status: COMPLETED | Results posted: 2022-11-25